THE WORLD MEDICINES SITUATION 2011

[1]  M. Rouse,et al.  Action! Update on the Global Pharmacy Education Consultation , 2008 .

[2]  S. Geest.  The articulation of formal and informal medicine distribution in South Cameroon , 1988 .

[3]  Adam Wagstaff,et al.  Catastrophe and impoverishment in paying for health care: with applications to Vietnam 1993-1998. , 2003, Health economics.

[4]  Matthew Hickman,et al.  HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage , 2010, The Lancet.

[5]  N. Barr.  Economics of the Welfare State , 1987 .

[6]  Matthew Hickman,et al.  Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review , 2008, The Lancet.

[7]  H. Leufkens,et al.  Pharmacovigilance of Biopharmaceuticals , 2009, Drug safety.

[8]  T. Umenai,et al.  Revolving drug funds: a step towards health security. , 1999, Bulletin of the World Health Organization.

[9]  A. Attaran,et al.  Antimalarial Drug Quality in the Most Severely Malarious Parts of Africa – A Six Country Study , 2008, PloS one.

[10]  C. Garg,et al.  Reducing out-of-pocket expenditures to reduce poverty: a disaggregated analysis at rural-urban and state level in India. , 2009, Health policy and planning.

[11]  D. Evans,et al.  Protecting households from catastrophic health spending. , 2007, Health affairs.

[12]  Z. Kirtava,et al.  The burden of out-of-pocket payments for health care in Tbilisi, Republic of Georgia. , 2002, JAMA.

[13]  A. Blenkinsopp,et al.  Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. , 2003, Journal of public health medicine.

[14]  B. Fogle.  News and Analysis , 1989 .

[15]  Robert Cook,et al.  The Population Reference Bureau , 1953, Science.

[16]  S. Hill,et al.  Setting standards for essential children's medicines. , 2007, Bulletin of the World Health Organization.

[17]  J. Grimshaw,et al.  From best evidence to best practice: effective implementation of change in patients' care , 2003, The Lancet.

[18]  O. Morgenthaler,et al.  Proceedings of the Conference , 1930 .

[19]  C. Anderson.  Academic and institutional capacity: a global issue. , 2008, American Journal of Pharmaceutical Education.

[20]  A. Mills,et al.  Community financing of health care in Africa: an evaluation of the Bamako initiative. , 1993, Social science & medicine.

[21]  M. Ngoasong.  The emergence of global health partnerships as facilitators of access to medication in Africa: a narrative policy analysis. , 2009, Social science & medicine.

[22]  N. Kanji.  Charging for drugs in Africa: UNICEF'S ‘Bamako Initiative’ , 1989 .

[23]  Elias Mossialos,et al.  Policies and Incentives for Promoting Innovation in Antibiotic Research , 2010 .

[24]  Maureen Lewis.  Informal Payments and the Financing of Health Care in Developing and Transition Countries , 2007, Health affairs.

[25]  T. Chen,et al.  Rural community pharmacy: a feasible site for a health promotion and screening service for cardiovascular risk factors. , 2003, The Australian journal of rural health.

[26]  J. Andrus,et al.  Regional group purchasing of vaccines: review of the Pan American Health Organization EPI revolving fund and the Gulf Cooperation Council group purchasing program. , 2006, The International journal of health planning and management.

[27]  C. Gaither,et al.  Should I stay or should I go? The influence of individual and organizational factors on pharmacists' future work plans. , 2007, Journal of the American Pharmacists Association : JAPhA.

[28]  E. Ombaka.  Current status of medicines procurement. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[29]  N. Simionescu,et al.  The Cardiovascular System , 1983 .

[30]  J. Donahue,et al.  The political economy of responsibility in health and illness. , 1995, Social science & medicine.

[31]  F. Ssali,et al.  Appropriate treatment of malaria? Use of antimalarial drugs for children's fevers in district medical units, drug shops and homes in eastern Uganda , 2002, Tropical medicine & international health : TM & IH.

[32]  Guilbert Jj.  The World Health Report 2006: working together for health. , 2006 .

[33]  Crime.,et al.  WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users.. , 2009 .

[34]  E. Bruera,et al.  Potent Analgesics Are More Expensive for Patients in Developing Countries , 2004, Journal of pain & palliative care pharmacotherapy.

[35]  Gretchen A. Stevens,et al.  National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants , 2011, The Lancet.

[36]  C. Correa.  Integrating public health concerns into patent legislation in developing countries , 2000 .

[37]  Elias Mossialos,et al.  Regulating Private Health Insurance in the European Union: The Implications of Single Market Legislation and Competition Policy , 2007 .

[38]  B. Stuart,et al.  Are Prescribed and Over‐the-Counter Medicines Economic Substitutes?: A Study of the Effects of Health Insurance on Medicine Choices by the Elderly , 1995, Medical care.

[39]  D. Peters,et al.  Poverty and Access to Health Care in Developing Countries , 2008, Annals of the New York Academy of Sciences.

[40]  F. Ogata,et al.  Effects of essential medicines on cardiovascular products available for the market in Thailand. , 2007, Health policy.

[41]  Daniel Cressey,et al.  Traditional drug-discovery model ripe for reform , 2011, Nature.

[42]  B. Meessen,et al.  Access to health care for all? User fees plus a Health Equity Fund in Sotnikum, Cambodia. , 2004, Health policy and planning.

[43]  B. Uzochukwu,et al.  Examining catastrophic costs and benefit incidence of subsidized antiretroviral treatment (ART) programme in south-east Nigeria. , 2009, Health policy.

[44]  J M Grimshaw,et al.  Effectiveness and efficiency of guideline dissemination and implementation strategies , 2004, International Journal of Technology Assessment in Health Care.

[45]  T. Ensor.  Informal payments for health care in transition economies. , 2004, Social science & medicine.

[46]  S. Shakir,et al.  Prescription–Event Monitoring , 2012 .

[47]  S. Brophy,et al.  Interventions for latent autoimmune diabetes (LADA) in adults. , 2011, The Cochrane database of systematic reviews.

[48]  F. Hawking.  Book reviewThe selection of essential drugs: Report of a WHO Expert Committee, 1977. WHO Technical Report Series, No. 615. Geneva, WHO, 36 pp. (ISBN 92 4 120615 2) , 1978 .

[49]  C. Raehl,et al.  Clinical Pharmacy Services, Pharmacist Staffing, and Drug Costs in United States Hospitals , 1999, Pharmacotherapy.

[50]  H. Leufkens,et al.  No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products - a pilot study , 2009, Orphanet journal of rare diseases.

[51]  L. Härmark,et al.  Pharmacovigilance: methods, recent developments and future perspectives , 2008, European Journal of Clinical Pharmacology.

[52]  R. Allan.  Innovating for health: patients, physicians, the pharmaceutical industry and the NHS , 2009 .

[53]  H. Goossens,et al.  Antibiotic consumption and link to resistance. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[54]  S. Geest,et al.  The Context of Medicines in Developing Countries , 1988 .

[55]  Christopher J L Murray,et al.  Health systems performance assessment: debates, methods and empiricism. , 2003 .

[56]  Elizabeth Docteur,et al.  Pharmaceutical pricing policies in a global market , 2008 .

[57]  R. Hartog.  Essential and non-essential drugs marketed by the 20 largest European pharmaceutical companies in developing countries. , 1993, Social science & medicine.

[58]  Kate Lorig,et al.  Patients as partners in managing chronic disease , 2000, BMJ : British Medical Journal.

[59]  M. Gemmill,et al.  International Journal for Equity in Health Open Access What Impact Do Prescription Drug Charges Have on Efficiency and Equity? Evidence from High-income Countries , 2008 .

[60]  Alan D. Lopez,et al.  Measuring the accumulated hazards of smoking: global and regional estimates for 2000 , 2003, Tobacco control.

[61]  D. Joranson,et al.  Ensuring opioid availability: methods and resources. , 2007, Journal of pain and symptom management.

[62]  J. Rho,et al.  Counting the Costs of Drug-Related Adverse Events , 1999, PharmacoEconomics.

[63]  Majid Ezzati,et al.  Smoking and oral tobacco use , 2004 .

[64]  P. Böelle,et al.  Significant Reduction of Antibiotic Use in the Community after a Nationwide Campaign in France, 2002–2007 , 2009, PLoS medicine.

[65]  T. Walley,et al.  Comparison of national administrative and commercial databases to monitor expenditure and costs of statins across Europe , 2004, European Journal of Clinical Pharmacology.

[66]  M. Mckee,et al.  Understanding informal payments for health care: the example of Bulgaria. , 2002, Health policy.

[67]  C. Wills.  Review: evidence on the effectiveness of interventions to improve patient adherence to prescribed medications is limited , 2008, Evidence-Based Nursing.

[68]  G. Carrin.  Social Health Insurance in Developing Countries: A Continuing Challenge , 2002 .

[69]  J. Anker,et al.  Pharmaceuticals and children. , 2004 .

[70]  P. Ghei,et al.  How to investigate drug use in health facilities. Selected drug use indicators : WHO Publications, Geneva, 87 pp., 1993 , 1995 .

[71]  D. Andrulis.  Community, service, and policy strategies to improve health care access in the changing urban environment. , 2000, American journal of public health.

[72]  C. Whitty,et al.  Effect of Removing Direct Payment for Health Care on Utilisation and Health Outcomes in Ghanaian Children: A Randomised Controlled Trial , 2009, PLoS medicine.

[73]  Okoro Ba,et al.  Pattern of drug therapy in home management of diarrhoea in rural communities of Nigeria. , 1995 .

[74]  Sallie-Anne Pearson,et al.  Interventions designed to improve the quality and efficiency of medication use in managed care: A critical review of the literature – 2001–2007 , 2008, BMC health services research.

[75]  T. Walley,et al.  The UK General Practice Research Database , 1997, The Lancet.

[76]  Joseph F. Lucke,et al.  Health Policy & Systems , 2001 .

[77]  T. Bodenheimer,et al.  Patient self-management of chronic disease in primary care. , 2002, JAMA.

[78]  O. Onwujekwe,et al.  Effect of the Bamako-Initiative drug revolving fund on availability and rational use of essential drugs in primary health care facilities in south-east Nigeria. , 2002, Health policy and planning.

[79]  Andrew D Oxman,et al.  Improving the use of research evidence in guideline development , 2007 .

[80]  Jane M. Young,et al.  Audit and feedback: effects on professional practice and healthcare outcomes. , 2012, The Cochrane database of systematic reviews.

[81]  E. Docteur,et al.  Pharmaceutical Pricing and Reimbursement Policies in Switzerland , 2007 .

[82]  Anke J. E. de Veer,et al.  Factors influencing the implementation of clinical guidelines for health care professionals: A systematic meta-review , 2008, BMC Medical Informatics Decis. Mak..

[83]  H. Goossens,et al.  Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[84]  S. Nwaka,et al.  The African Network for Drugs and Diagnostics Innovation , 2009, The Lancet.

[85]  P. Aslani,et al.  Factors affecting the recruitment and retention of pharmacists to practice sites in rural and remote areas of New South Wales: a qualitative study. , 2006, The Australian journal of rural health.

[86]  Mdg Gap Task Force.  Delivering on the global partnership for achieving the millennium development goals : Millennium Development Goal 8 : , 2008 .

[87]  S. Desselle.  Job turnover intentions among Certified Pharmacy Technicians. , 2005, Journal of the American Pharmacists Association : JAPhA.

[88]  S. Bosnic-Anticevich,et al.  Innovative asthma health promotion by rural community pharmacists: a feasibility study. , 2005, Health promotion journal of Australia : official journal of Australian Association of Health Promotion Professionals.

[89]  R. Tahar,et al.  Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children. , 2007, Acta tropica.

[90]  P. Berman,et al.  Informal payments in the health sector: a case study from Turkey. , 2007, Health affairs.

[91]  F. LuisBavestrello,et al.  Impacto de medidas regulatorias en la tendencia de consumo comunitario de antibióticos en Chile , 2002 .

[92]  S. Dagogo-Jack.  Primary prevention of type-2 diabetes in developing countries. , 2006, Journal of the National Medical Association.

[93]  J. Campos,et al.  Self-medication with Antimicrobial Drugs in Europe , 2006, Emerging infectious diseases.

[94]  D. Livermore.  Bacterial resistance: origins, epidemiology, and impact. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[95]  A. Oxman,et al.  Pharmaceutical policies: effects of cap and co-payment on rational drug use. , 2008, The Cochrane database of systematic reviews.

[96]  Ke Xu,et al.  Coping with out-of-pocket health payments: empirical evidence from 15 African countries. , 2008, Bulletin of the World Health Organization.

[97]  L. Simonsen,et al.  Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. , 1999, Bulletin of the World Health Organization.

[98]  S. Soumerai,et al.  Antibiotic use following a Korean national policy to prohibit medication dispensing by physicians. , 2005, Health policy and planning.

[99]  Marko Vujicic,et al.  The role of wages in the migration of health care professionals from developing countries , 2004, Human resources for health.

[100]  Alasdair Breckenridge,et al.  Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma , 2008, Nature Reviews Drug Discovery.

[101]  C. Murray,et al.  Household catastrophic health expenditure: a multicountry analysis , 2003, The Lancet.

[102]  C. Etienne,et al.  Health systems financing and the path to universal coverage. , 2010, Bulletin of the World Health Organization.

[103]  Cui Weiyuan,et al.  China's village doctors take great strides. , 2008, Bulletin of the World Health Organization.

[104]  D. Jamison,et al.  Disease control priorities in developing countries, second edition , 2006 .

[105]  A. Mills,et al.  Retail supply of malaria‐related drugs in rural Tanzania: risks and opportunities , 2004, Tropical medicine & international health : TM & IH.

[106]  M. Rouse,et al.  Needs-Based Education in the Context of Globalization , 2012, American Journal of Pharmaceutical Education.

[107]  W. Mcfarland,et al.  Provision of Syndromic Treatment of Sexually Transmitted Infections by Community Pharmacists: A Potentially Underutilized HIV Prevention Strategy , 2003, Sexually transmitted diseases.

[108]  L. Matowe,et al.  Existing capacity to manage pharmaceuticals and related commodities in East Africa: an assessment with specific reference to antiretroviral therapy , 2009, Human resources for health.

[109]  G. Carrin,et al.  Community‐based health insurance in developing countries: a study of its contribution to the performance of health financing systems , 2005, Tropical medicine & international health : TM & IH.

[110]  C. Warren,et al.  Patterns of global tobacco use in young people and implications for future chronic disease burden in adults , 2006, The Lancet.

[111]  Lisa Hitchen,et al.  Adverse drug reactions result in 250 000 UK admissions a year , 2006, BMJ : British Medical Journal.

[112]  L. Hazell,et al.  Under-Reporting of Adverse Drug Reactions , 2006, Drug safety.

[113]  A. Sánchez,et al.  Decentralizing and integrating contraceptive logistics systems in Latin America and the Caribbean. Considerations for informed decision making throughout the health reform process. , 2006 .

[114]  M. Adikwu.  Sales practices of patent medicine sellers in Nigeria. , 1996, Health policy and planning.

[115]  J. Gribble,et al.  Options for contraceptive procurement: lessons learned from Latin America and the Caribbean. , 2006 .

[116]  A. Herxheimer,et al.  A comparison of adverse drug reaction reports from professionals and users, relating to risk of dependence and suicidal behaviour with paroxetine , 2004 .

[117]  R. Snow,et al.  The role of shops in the treatment and prevention of childhood malaria on the coast of Kenya. , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[118]  P. Garner,et al.  Contracts between patients and healthcare practitioners for improving patients' adherence to treatment, prevention and health promotion activities. , 2007, The Cochrane database of systematic reviews.

[119]  H. Leufkens,et al.  Rare essentials: drugs for rare diseases as essential medicines. , 2006, Bulletin of the World Health Organization.

[120]  Bruce Neal,et al.  Priority medicines for Europe and the world , 2004 .

[121]  L. Grigoryan.  Self-medication with antibiotics in Europe and its determinants , 2007 .

[122]  M. Tinetti.  Over-the-counter sales of statins and other drugs for asymptomatic conditions. , 2008, The New England journal of medicine.

[123]  P. Munderi,et al.  Prescription for healthy development : increasing access to medicines , 2005 .

[124]  M. Casey,et al.  Pharmacist staffing, technology use, and implementation of medication safety practices in rural hospitals. , 2006, The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association.

[125]  E. Johansson.  Future developments in hormonal contraception. , 2004, American journal of obstetrics and gynecology.

[126]  C. Raehl,et al.  Clinical Pharmacy Services, Pharmacy Staffing, and Hospital Mortality Rates , 2007, Pharmacotherapy.

[127]  David M. Dror,et al.  Micro-Insurance: Extending Health Insurance to the Excluded , 1999 .

[128]  M. McCord.  Health care microinsurance - case studies from Uganda, Tanzania, India and Cambodia , 2001 .

[129]  I. Kibwage,et al.  A strategy to improve skills in pharmaceutical supply management in East Africa: the regional technical resource collaboration for pharmaceutical management , 2008, Human resources for health.

[130]  M. Zaffran,et al.  Ensuring Supplies of Appropriate Drugs and Vaccines , 2006 .

[131]  Robert Matiru,et al.  The Global Drug Facility: a unique, holistic and pioneering approach to drug procurement and management. , 2007, Bulletin of the World Health Organization.

[132]  K. Woldeyesus,et al.  Operational principles for good pharmaceutical procurement. , 1999 .

[133]  C. Lengeler,et al.  Malaria treatment in the retail sector: Knowledge and practices of drug sellers in rural Tanzania , 2008, BMC public health.

[134]  D. A. Knapp.  Professionally Determined Need for Pharmacy Services in 2020 1 , 2002 .

[135]  J. Amon,et al.  Access to pain treatment as a human right , 2010, BMC medicine.

[136]  A. Kamarulzaman,et al.  Malaysia and harm reduction: the challenges and responses. , 2007, The International journal on drug policy.

[137]  I. Choonara.  WHO wants safer medicines for children , 2008, Archives of Disease in Childhood.

[138]  Tana Wuliji.  Current status of human resources and training in hospital pharmacy. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[139]  M. Montgomery.  Urban poverty and health in developing countries. , 2009 .

[140]  W. Gilmore,et al.  Commentary on the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988 , 1998 .

[141]  P. Corey,et al.  Incidence of Adverse Drug Reactions in Hospitalized Patients , 2012 .

[142]  W. Savedoff,et al.  Private health insurance: implications for developing countries. , 2005, Bulletin of the World Health Organization.

[143]  H. Leufkens,et al.  Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases. , 2009, Bulletin of the World Health Organization.

[144]  M. Uplekar,et al.  Tuberculosis patients and practitioners in private clinics in India. , 1998, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[145]  R. Grol,et al.  Antibiotic prescribing in primary care: first choice and restrictive prescribing are two different traits , 2007, Quality and Safety in Health Care.

[146]  I. Bates,et al.  Migration as a form of workforce attrition: a nine-country study of pharmacists , 2009, Human resources for health.

[147]  S. McCombie.  Treatment seeking for malaria: a review of recent research. , 1996, Social science & medicine.

[148]  Tim Evans,et al.  Tackling the challenges to health equity in China , 2008, The Lancet.

[149]  A. Pariente,et al.  Prevalence and preventability of adverse drug events in a teaching hospital: a cross-sectional study. , 2009, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[150]  S. Russell.  Illuminating cases: understanding the economic burden of illness through case study household research. , 2005, Health policy and planning.

[151]  E. Krakauer,et al.  Opioid Inaccessibility and Its Human Consequences: Reports From the Field , 2010, Journal of pain & palliative care pharmacotherapy.

[152]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[153]  Matthew H. Samore,et al.  Antimicrobial Resistance Determinants and Future Control , 2005, Emerging infectious diseases.

[154]  R. Brian Haynes,et al.  Compliance in Health Care , 1979 .

[155]  S. Ochola,et al.  Impact of ministry of health interventions on private medicine retailer knowledge and practices on anti-malarial treatment in Kenya. , 2009, The American journal of tropical medicine and hygiene.

[156]  T. Tupasi,et al.  Purchase of antibiotics without prescription in Manila, the Philippines. Inappropriate choices and doses. , 1990, Journal of clinical epidemiology.

[157]  A. C. Lin,et al.  Effect of a robotic prescription-filling system on pharmacy staff activities and prescription-filling time. , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[158]  I. Okeke,et al.  Antimicrobial resistance in developing countries , 1998, BMJ.

[159]  C. Murray,et al.  Summary measures of the distribution of household financial contributions to health , 2003 .

[160]  Sangeeta Sharma,et al.  Insights for policymakers from a medicine price survey in Rajasthan. , 2009, The Indian journal of medical research.

[161]  Steve Reid,et al.  A critical review of interventions to redress the inequitable distribution of healthcare professionals to rural and remote areas. , 2009, Rural and remote health.

[162]  Elias Mossialos,et al.  Voluntary health insurance in the European Union , 2004 .

[163]  R. Sauerborn,et al.  Household strategies to cope with the economic costs of illness. , 1996, Social science & medicine.

[164]  C. Goodman,et al.  Improving the Supply Distribution and Use of Antimalarial Drugs by the Private Sector in Tanzania. Report prepared for the National Malaria Control Programme, United Republic of Tanzania , 2003 .

[165]  J. Plessis.  The Chronic Dispensing Unit , 2008 .

[166]  D. Morley,et al.  Reaching health for all , 1993 .

[167]  S. Sirima,et al.  Letter to the Editor: Artemisinin‐based combination treatment in home‐based management of malaria , 2005, Tropical medicine & international health : TM & IH.

[168]  Cohen Wd,et al.  Managing the change process. , 1995 .

[169]  M. Lindquist,et al.  A Data Mining Approach for Signal Detection and Analysis , 2002, Drug safety.

[170]  A. Muula,et al.  Human resources requirements for highly active antiretroviral therapy scale-up in Malawi , 2007, BMC Health Services Research.

[171]  S. Shakir,et al.  An Assessment of the Publicly Disseminated Evidence of Safety Used in Decisions to Withdraw Medicinal Products from the UK and US Markets , 2006, Drug safety.

[172]  B. Phommasack,et al.  Revolving drug funds at front-line health facilities in Vientiane, Lao PDR. , 2001, Health policy and planning.

[173]  Claire Anderson,et al.  The global pharmacy workforce: a systematic review of the literature , 2009, Human Resources for Health.

[174]  Mamas Theodorou,et al.  Informal payments in public hospitals in Greece. , 2008, Health policy.

[175]  S. Adjei,et al.  Pharmacists' role in managing sexually transmitted infections: policy issues and options for Ghana. , 2001, Health policy and planning.

[176]  K. Knapp,et al.  Factors influencing the pharmacy faculty workforce. , 2008, American journal of pharmaceutical education.

[177]  L. Atuyambe,et al.  Maintaining quality of health services after abolition of user fees: A Uganda case study , 2008, BMC health services research.

[178]  Melinda Moore,et al.  Global urbanization and impact on health. , 2003, International journal of hygiene and environmental health.

[179]  Dennis Ross-Degnan,et al.  Medicine access and utilization in a population covered by primary health care in Brazil. , 2009, Health policy.

[180]  J. Epping-Jordan,et al.  Innovative care for chronic conditions: building blocks for action , 2002 .

[181]  M. Gissler,et al.  Nordic Medical Birth Registers in epidemiological research , 1997, European Journal of Epidemiology.

[182]  K. Lindblade,et al.  Treatment for clinical malaria is sought promptly during an epidemic in a highland region of Uganda , 2000, Tropical medicine & international health : TM & IH.

[183]  K. Fukino,et al.  The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. , 2007, Bulletin of the World Health Organization.

[184]  C. Raehl,et al.  Evidence‐Based Core Clinical Pharmacy Services in United States Hospitals in 2020: Services and Staffing , 2004, Pharmacotherapy.

[185]  B. Abel-Smith,et al.  Health insurance in developing countries: lessons from experience. , 1992, Health policy and planning.

[186]  B. Motheral,et al.  Effect of a Three-Tier Prescription Copay on Pharmaceutical and Other Medical Utilization , 2001, Medical care.

[187]  D. Beck,et al.  The WHO UNESCO FIP Pharmacy Education Taskforce , 2009, Human resources for health.

[188]  S. Janković,et al.  Public drug procurement: the lessons from a drug tender in a teaching hospital of a transition country , 2004, European Journal of Clinical Pharmacology.

[189]  Patrick Mayeux,et al.  Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. , 2002, The New England journal of medicine.

[190]  E. Vermeire,et al.  Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. , 2005, The Cochrane database of systematic reviews.

[191]  Oladimeji Oladepo,et al.  Interactions between patent medicine vendors and customers in urban and rural Nigeria. , 2004, Health policy and planning.

[192]  K. Sikora,et al.  Essential drugs for cancer therapy: a World Health Organization consultation. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[193]  D. Woodle,et al.  Vaccine procurement and self-sufficiency in developing countries. , 2000, Health policy and planning.

[194]  B. Uzochukwu,et al.  An in-depth study of patent medicine sellers' perspectives on malaria in a rural Nigerian community , 2006, Malaria Journal.

[195]  K. Tin,et al.  Catastrophic payments for health care in Asia. , 2007, Health economics.

[196]  E. Schokkaert,et al.  Risk adjustment and risk selection on the sickness fund insurance market in five European countries. , 2003, Health policy.

[197]  Augusto Silva,et al.  National community health insurance at village level: the case from Guinea Bissau , 1991 .

[198]  D. Leon.  Cities, urbanization and health. , 2008, International journal of epidemiology.

[199]  S. van Dulmen,et al.  Patient adherence to medical treatment: a review of reviews , 2007, BMC Health Services Research.

[200]  J. Feely,et al.  Underreporting of Adverse Drug Reactions: Attitudes of Irish doctors , 1999, Irish journal of medical science.

[201]  P. Shankar.  Medicines use in primary care in developing and transitional countries: fact book summarizing results from studies reported between 1990 and 2006. , 2009 .

[202]  R. Duggal.  Poverty & health: criticality of public financing. , 2007, The Indian journal of medical research.

[203]  B. Uzochukwu,et al.  Inequities in valuation of benefits, choice of drugs, and mode of payment for malaria treatment services provided by community health workers in Nigeria. , 2007, The American journal of tropical medicine and hygiene.

[204]  B. Abel-Smith,et al.  Community-financing in developing countries: the potential for the health sector , 1988 .

[205]  Joshua Lederberg,et al.  Microbial Threats to Health: Emergence, Detection, and Response , 2003 .

[206]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[207]  S. Teutsch,et al.  Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization. , 2005, The American journal of managed care.

[208]  Przemyslaw Kardas,et al.  Non-compliance with antibiotic therapy for acute community infections: a global survey. , 2007, International journal of antimicrobial agents.

[209]  S. Galea,et al.  Urban health: evidence, challenges, and directions. , 2005, Annual review of public health.

[210]  J. Epping-Jordan,et al.  The challenge of chronic conditions: WHO responds , 2001, BMJ : British Medical Journal.

[211]  Ainara Campino,et al.  Mejores medicamentos en pediatría , 2011 .

[212]  Asher Mullard,et al.  2010 FDA drug approvals , 2011, Nature Reviews Drug Discovery.

[213]  N. Cranswick,et al.  Improving drug use for children in the developing world , 2005, Archives of Disease in Childhood.

[214]  B. Munos.  Lessons from 60 years of pharmaceutical innovation , 2009, Nature Reviews Drug Discovery.

[215]  C. Goodman.  An economic analysis of the retail market for fever and malaria treatment in rural Tanzania , 2005 .

[216]  Taghreed Adam,et al.  The burden and costs of chronic diseases in low-income and middle-income countries , 2007, The Lancet.

[217]  Inke Mathauer,et al.  Health worker motivation in Africa: the role of non-financial incentives and human resource management tools , 2006, Human resources for health.

[218]  M. Pauly,et al.  Private health insurance in developing countries. , 2006, Health affairs.

[219]  M. Reich.  The politics of health sector reform in developing countries: three cases of pharmaceutical policy. , 1995, Health policy.

[220]  G. Mwabu,et al.  User charges in government health facilities in Kenya: effect on attendance and revenue. , 1995, Health policy and planning.

[221]  A. Barr,et al.  For Public Service or Money: Understanding Geographical Imbalances in the Health Workforce , 2005, Health policy and planning.

[222]  J. Kremer,et al.  The role of drug and disease registries in rheumatic disease epidemiology , 2008, Current opinion in rheumatology.

[223]  E. Cox,et al.  Medicare Beneficiaries’ Management of Capped Prescription Benefits , 2001, Medical care.

[224]  Xin Li,et al.  The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities. , 2007, Health policy.

[225]  J. Guo,et al.  Rare diseases and legislation in China , 2010, The Lancet.

[226]  L. D. Lima.  Opioid Availability in Latin America as a Global Problem: A New Strategy with Regional and National Effects , 2004 .

[227]  M. Ryan,et al.  Charging for health care: evidence on the utilisation of NHS prescribed drugs. , 1991, Social science & medicine.

[228]  N J Wald,et al.  A strategy to reduce cardiovascular disease by more than 80% , 2003, BMJ : British Medical Journal.

[229]  M. Claeson,et al.  The millennium development goals for health - rising to the challenges , 2004 .

[230]  C. vanMosseveld.  Pharmaceutical expenditure compared across countries. , 2005 .

[231]  N. J. Howard,et al.  Changes in the World Health Organisation essential drug list , 1991, The Lancet.

[232]  M. Dickson,et al.  Pharmaceutical Use and Expenditure for Cardiovascular Disease and Stroke , 2003 .

[233]  Tim Evans,et al.  An assessment of interactions between global health initiatives and country health systems , 2009, The Lancet.

[234]  S. Levy.  Antibiotic resistance-the problem intensifies. , 2005, Advanced drug delivery reviews.

[235]  I. Edwards,et al.  Detecting medication errors in pharmacovigilance database: Capacities and limits , 2007 .

[236]  A. Creese,et al.  Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia , 2007, PLoS medicine.

[237]  C. Raehl,et al.  Clinical Pharmacy Services, Pharmacy Staffing, and the Total Cost of Care in United States Hospitals , 2000, Pharmacotherapy.

[238]  A. Kotwani.  Availability, price and affordability of asthma medicines in five Indian states. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[239]  Ruth Bonita,et al.  Women, aging and health : achieving health across the life span , 1996 .

[240]  D. Hotchkiss,et al.  Household health expenditures in Nepal: implications for health care financing reform. , 1998, Health policy and planning.

[241]  A. Kotwani,et al.  Prices & availability of common medicines at six sites in India using a standard methodology. , 2007, The Indian journal of medical research.

[242]  Thomas J. Johnson.  Pharmacist work force in 2020: implications of requiring residency training for practice. , 2008, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[243]  Robert W Snow,et al.  The use of formal and informal curative services in the management of paediatric fevers in four districts in Kenya , 2003, Tropical medicine & international health : TM & IH.

[244]  D. Vanuzzo,et al.  [Pharmacological therapy of obesity]. , 2008, Giornale italiano di cardiologia.

[245]  R. Snow,et al.  Intra-household relations and treatment decision-making for childhood illness: a Kenyan case study. , 2002, Journal of biosocial science.

[246]  Rocky Mountain.  PUBLIC HEALTH FACT SHEET , 2007 .

[247]  D. Peters,et al.  Malaria treatment and policy in three regions in Nigeria: The role of patent medicine vendors. , 2007 .

[248]  A. Dodoo,et al.  When rumours derail a mass deworming exercise , 2007, The Lancet.

[249]  A. Avery,et al.  Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study , 2003, Quality & safety in health care.

[250]  K. Kinsella,et al.  An aging world: 2008. , 2009 .

[251]  T. Egberts,et al.  Evaluation of Post-Authorization Safety Studies in the First Cohort of EU Risk Management Plans at Time of Regulatory Approval , 2009, Drug Safety.

[252]  Charles C. Persinger,et al.  How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.

[253]  Diederick Grobbee,et al.  Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.

[254]  D Ross-Degnan,et al.  Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis , 2009, The Lancet.

[255]  Andy Gray,et al.  The Selection and Use of Essential Medicines. , 2015, World Health Organization technical report series.

[256]  F. Andersson.  Methodological Aspects of International Drug Price Comparisons , 1993, PharmacoEconomics.

[257]  A. Banerjee,et al.  The Economic Lives of the Poor , 2006, The journal of economic perspectives : a journal of the American Economic Association.

[258]  L. Gostin,et al.  Ensuring Effective Pain Treatment: A National and Global Perspective , 2008, JAMA.

[259]  K. Reynolds,et al.  Global burden of obesity in 2005 and projections to 2030 , 2008, International Journal of Obesity.

[260]  S. Kopp.  GOOD DISTRIBUTION PRACTICES (GDP) FOR PHARMACEUTICAL PRODUCTS , 2005 .

[261]  D. Carr,et al.  Pain Management: A Fundamental Human Right , 2007, Anesthesia and analgesia.

[262]  Bethan Hughes,et al.  2009 FDA drug approvals , 2010, Nature Reviews Drug Discovery.

[263]  C. Beyrer,et al.  Time to act: a call for comprehensive responses to HIV in people who use drugs , 2010, The Lancet.

[264]  S. Russell,et al.  Ability to pay for health care: concepts and evidence. , 1996, Health policy and planning.

[265]  S. Tregear,et al.  Long-term opioid therapy for chronic noncancer pain: a systematic review and meta-analysis of efficacy and safety. , 2008, Journal of pain and symptom management.

[266]  K. O’Leary,et al.  Snapshot of the Australian Public Hospital Pharmacy Workforce in 2003 , 2004 .

[267]  Ke Xu,et al.  Universal coverage of health services: tailoring its implementation , 2008 .

[268]  C. Raehl,et al.  The Feasibility of Implementing an Evidence‐Based Core Set of Clinical Pharmacy Services in 2020: Manpower, Marketplace Factors, and Pharmacy Leadership , 2004, Pharmacotherapy.

[269]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[270]  N. Ford,et al.  Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand , 2007, AIDS.

[271]  H. Goossens,et al.  Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. , 2007, The Journal of antimicrobial chemotherapy.

[272]  V. Miller.  ARV DRUGS, ADVERSE EVENTS, CASE DEFINITION, GRADING, LABORATORY DIAGNOSIS AND TREATMENT MONITORING , 2010 .

[273]  J A Hanley,et al.  Adverse events associated with prescription drug cost-sharing among poor and elderly persons. , 2001, JAMA.

[274]  R. Mpembeni,et al.  Coping with private health markets: regulatory effectiveness in Sub-Saharan Africa , 2003 .

[275]  Margaret Alston,et al.  'It's All Part of the Package' in Rural Allied Health Work: A Pilot Study of Rewards and Barriers in Rural Pharmacy and Social Work , 2007 .